| Financial Year |
March 31 2023 |
| Monetary Funds |
215,205,248.38 |
| Held-for-trading Financial Assets |
124.54 |
| Notes Receivable |
1,287,250.00 |
| Accounts Receivable |
56,681,557.34 |
| Advances to Suppliers |
3,322,850.15 |
| Other Receivables |
3,700,649.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
142,580,556.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
721,365.54 |
| Other Current Assets |
10,987,859.61 |
| Total Current Assets |
457,395,505.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,150,000.00 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
78,128,995.22 |
| Under-construction Projects |
108,595,518.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,273,492.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,000,154.77 |
| Deferred Income Tax Assets |
3,657,657.59 |
| Other Non-Current Assets |
205,139,987.94 |
| Sub-Total of Non-Current Assets |
455,627,154.14 |
| Total Assets |
913,022,659.93 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
17,854,484.01 |
| Accounts Payable |
39,361,934.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
924,432.90 |
| Taxes Payable |
2,924,548.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
501,074.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,240,177.58 |
| Other Current Liabilities |
4,493,194.46 |
| Sub-Total of Current Liabilities |
125,429,962.78 |
| Long-term Loans |
79,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
84,946,270.37 |
| Total Liabilities |
210,376,233.15 |
| Paid-In Capital(Or Share Stock) |
62,400,000.00 |
| Capital Surplus |
446,481,630.42 |
| Surplus Reserve |
27,995,978.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
152,408,505.35 |
| Minority Stockholder's Interest |
13,360,312.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
689,286,114.25 |
| Owner's Equity（Stockholder's Equity） |
702,646,426.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
913,022,659.93 |
